Current Controversies in Melanoma Treatment | Journal CME Article-Journal CME Article: Current Controversies in Melanoma Treatment V5

Journal CME Article: Current Controversies in Melanoma Treatment V5

Video Transcription

Video Summary

The presentation details the use of interleukin-2 (IL-2) injections to treat in-transit melanoma metastasis. Patients received four sets of bi-weekly IL-2 injections, leading to complete resolution of lesions. The procedure involves cleansing injection sites, using tuberculin syringes, and injecting 2.4 milliliters of reconstituted IL-2 into lesions. While treatment is generally well tolerated, patients may experience manageable fever and chills post-injection. The procedure has demonstrated durable complete responses in melanoma cases.

Keywords

interleukin-2

melanoma metastasis

IL-2 injections

treatment procedure

complete response